Cypress Capital Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$392K Buy
4,501
+593
+15% +$51.7K 0.05% 170
2025
Q1
$351K Sell
3,908
-2,966
-43% -$267K 0.05% 166
2024
Q4
$549K Sell
6,874
-5,599
-45% -$447K 0.07% 173
2024
Q3
$1.12M Buy
12,473
+2,798
+29% +$252K 0.13% 129
2024
Q2
$762K Sell
9,675
-34
-0.4% -$2.68K 0.09% 168
2024
Q1
$846K Sell
9,709
-14
-0.1% -$1.22K 0.1% 169
2023
Q4
$801K Buy
9,723
+814
+9% +$67.1K 0.1% 168
2023
Q3
$698K Buy
8,909
+593
+7% +$46.5K 0.1% 179
2023
Q2
$733K Buy
8,316
+594
+8% +$52.3K 0.11% 184
2023
Q1
$623K Buy
+7,722
New +$623K 0.1% 194
2022
Q3
Sell
-4,099
Closed -$368K 287
2022
Q2
$368K Sell
4,099
-260
-6% -$23.3K 0.06% 226
2022
Q1
$484K Buy
4,359
+468
+12% +$52K 0.06% 219
2021
Q4
$403K Buy
3,891
+366
+10% +$37.9K 0.05% 228
2021
Q3
$442K Hold
3,525
0.06% 219
2021
Q2
$438K Sell
3,525
-98
-3% -$12.2K 0.06% 220
2021
Q1
$428K Sell
3,623
-1,576
-30% -$186K 0.06% 220
2020
Q4
$609K Buy
5,199
+1,030
+25% +$121K 0.09% 182
2020
Q3
$433K Sell
4,169
-714
-15% -$74.2K 0.07% 190
2020
Q2
$448K Buy
4,883
+1,325
+37% +$122K 0.08% 180
2020
Q1
$320K Buy
3,558
+153
+4% +$13.8K 0.07% 159
2019
Q4
$387K Buy
3,405
+232
+7% +$26.4K 0.07% 179
2019
Q3
$345K Buy
+3,173
New +$345K 0.07% 192
2018
Q1
Sell
-2,885
Closed -$233K 219
2017
Q4
$233K Buy
+2,885
New +$233K 0.05% 198
2016
Q4
Sell
-2,500
Closed -$216K 190
2016
Q3
$216K Sell
2,500
-525
-17% -$45.4K 0.05% 173
2016
Q2
$263K Buy
+3,025
New +$263K 0.06% 154
2016
Q1
Sell
-3,764
Closed -$290K 175
2015
Q4
$290K Buy
+3,764
New +$290K 0.07% 165
2015
Q3
Sell
-4,347
Closed -$322K 199
2015
Q2
$322K Hold
4,347
0.07% 168
2015
Q1
$339K Buy
4,347
+199
+5% +$15.5K 0.08% 171
2014
Q4
$299K Sell
4,148
-698
-14% -$50.3K 0.07% 189
2014
Q3
$301K Sell
4,846
-4,639
-49% -$288K 0.07% 175
2014
Q2
$605K Buy
9,485
+5,485
+137% +$350K 0.14% 122
2014
Q1
$246K Hold
4,000
0.06% 189
2013
Q4
$230K Hold
4,000
0.06% 194
2013
Q3
$213K Sell
4,000
-175
-4% -$9.32K 0.05% 195
2013
Q2
$215K Buy
+4,175
New +$215K 0.04% 203